Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.
about
Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).Reversible Cysteine Acylation Regulates the Activity of Human Palmitoyl-Protein Thioesterase 1 (PPT1).Homozygous PPT1 Splice Donor Mutation in a Cane Corso Dog With Neuronal Ceroid Lipofuscinosis
P2860
Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@ast
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@en
type
label
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@ast
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@en
prefLabel
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@ast
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@en
P2093
P2860
P356
P1476
Treatment of the Ppt1(-/-) mou ...... receptor antagonist memantine.
@en
P2093
Attila D Kovács
David A Pearce
Rozzy Finn
P2860
P304
P356
10.1177/0883073813494480
P577
2013-09-01T00:00:00Z